Clinical Trial Update: A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating nab-paclitaxel, gemcitabine, and cisplatin in unresectable biliary tract cancer; the trial is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Gemzar (gemcitabine) (gemcitabine)
• Nab-paclitaxel (Abraxane) (nab-paclitaxel)
• Platinol (Cisplatin) (Cisplatin)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Unresectable Biliary Tract Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING